-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, DxLOxypU4GuanM9o/sxITZOhFRW0A6VhApndh2AMCyMCEkB9+3++ruOXYIXZJVQP 1vF4FF5w80tz/j05fFteSw== 0001317757-08-000002.txt : 20081202 0001317757-08-000002.hdr.sgml : 20081202 20081202164137 ACCESSION NUMBER: 0001317757-08-000002 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20081201 FILED AS OF DATE: 20081202 DATE AS OF CHANGE: 20081202 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Healey Timothy G CENTRAL INDEX KEY: 0001382032 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-14732 FILM NUMBER: 081225471 BUSINESS ADDRESS: BUSINESS PHONE: 617-498-3300 MAIL ADDRESS: STREET 1: C/O ADVANCED MAGNETICS, INC. STREET 2: 125 CAMBRIDGEPARK DRIVE, 6TH FLOOR CITY: CAMBRIDGE STATE: MA ZIP: 02140 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: AMAG PHARMACEUTICALS INC. CENTRAL INDEX KEY: 0000792977 STANDARD INDUSTRIAL CLASSIFICATION: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835] IRS NUMBER: 042742593 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 100 HAYDEN AVENUE CITY: LEXINGTON STATE: MA ZIP: 02140 BUSINESS PHONE: 6174972070 MAIL ADDRESS: STREET 1: 100 HAYDEN AVENUE CITY: LEXINGTON STATE: MA ZIP: 02140 FORMER COMPANY: FORMER CONFORMED NAME: ADVANCED MAGNETICS INC DATE OF NAME CHANGE: 19920703 4 1 primary_doc.xml PRIMARY DOCUMENT X0303 4 2008-12-01 0 0000792977 AMAG PHARMACEUTICALS INC. AMAG 0001382032 Healey Timothy G C/O AMAG PHARMACEUTICALS, INC. 100 HAYDEN AVENUE LEXINGTON MA 02421 0 1 0 0 SVP - Commercial Operations Common Stock 2008-12-01 4 M 0 750 A 1419 D Common Stock 2008-12-01 4 S 0 750 32.86 D 669 D Common Stock 2008-12-01 4 S 0 270 32.86 D 399 D Restricted Stock Unit 0 2008-12-01 4 M 0 750 0 D Common Stock 750 1500 D The shares were acquired by the reporting person as a result of the partial vesting of a restricted stock unit grant described below. Not applicable. The sales reported on this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the reporting person. These shares were acquired by the reporting person pursuant to the Company's 2006 Employee Stock Purchase Plan. This restricted stock unit grant vests in four equal annual installments. The first installment vested on December 1, 2007. The second installment vested on December 1, 2008 and the remaining installments vest on December 1, 2009 and December 1, 2010. Joseph L. Farmer, attorney-in-fact 2008-12-02 -----END PRIVACY-ENHANCED MESSAGE-----